loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Latanoprost reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Latanoprost

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,321,571Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Mikeluna Combination Ophthalmic Solution

    02 2Xalabrands

    03 1Xalatan

    04 6Xalatan/Xalacom

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Xalatan/Xalacom

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Xalatan/Xalacom

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer Inc.

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2019 Revenue in Millions : 281

    2018 Revenue in Millions : 318

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Mikeluna Combination Ophthalmic Solution

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Mikeluna Combination Ophthalmic Solution

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2021 Revenue in Millions : 44

    2020 Revenue in Millions : 38

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Mikeluna Combination Ophthalmic Solution

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Mikeluna Combination Ophthalmic Solution

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2022 Revenue in Millions : 47

    2021 Revenue in Millions : 44

    Growth (%) : 7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Xalabrands

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Xalabrands

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Viatris

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2022 Revenue in Millions : 195

    2021 Revenue in Millions : 226

    Growth (%) : -14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Mikeluna Combination Ophthalmic Solution

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Mikeluna Combination Ophthalmic Solution

    Japan
    arrow
    Formnext Forum
    Not Confirmed

    Otsuka

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2023 Revenue in Millions : 46

    2022 Revenue in Millions : 47

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Xalabrands

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Xalabrands

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Viatris

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2023 Revenue in Millions : 193

    2022 Revenue in Millions : 195

    Growth (%) : -1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Xalatan

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Xalatan

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer Inc.

    Latanoprost

    Main Therapeutic Indication : Opthamology

    Currency : USD

    2014 Revenue in Millions : -16.00%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Xalatan/Xalacom

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Xalatan/Xalacom

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer Inc.

    Latanoprost

    Main Therapeutic Indication : Opthamology

    Currency : USD

    2015 Revenue in Millions : 495

    2014 Revenue in Millions : 399

    Growth (%) : -19%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Xalatan/Xalacom

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Xalatan/Xalacom

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2016 Revenue in Millions : 363

    2015 Revenue in Millions : 399

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Xalatan/Xalacom

    Latanoprost

    arrow
    Formnext Forum
    Not Confirmed

    Brand Name : Xalatan/Xalacom

    U.S.A
    arrow
    Formnext Forum
    Not Confirmed

    Pfizer Inc.

    Latanoprost

    Main Therapeutic Indication : Ophthalmology

    Currency : USD

    2017 Revenue in Millions : 335

    2016 Revenue in Millions : 362

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF